Influence of preexisting hepatitis C virus antibody positivity in simultaneous pancreas-kidney transplant recipients

Transplantation

Volumn 90, Issue 1, 2010, Pages 61-67

  Miguel, Maria ^a   Sampaio, Ms ^a,b   Kuo, Hung Tien ^a,c   Poommipanit, Neda ^a   Martin, Paul ^d   Bunnapradist, Suphamai ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HOSPITAL UNIVERSITÁRIO PEDRO ERNESTO   (Brazil)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Hepatitis C; Kidney transplant; Outcomes.; Pancreas transplant; Survival

Indexed keywords

CREATININE; HEPATITIS C ANTIBODY;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY PANCREAS TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; UNITED STATES;

ADULT; CADAVER; CAUSE OF DEATH; DISEASE PROGRESSION; FEMALE; GRAFT SURVIVAL; HEPATITIS C; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PANCREAS TRANSPLANTATION; TISSUE DONORS; UNITED STATES;

EID: 77954622474     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181e17032     Document Type: Article

References (28)

1. Wells JT, Lucey MR, Said A. Hepatitis C in transplant recipients of solid organs, other than liver. Clin Liver Dis 2006; 10: 901.
2. Fong TL, Hou L, Hutchinson IV, et al. Impact of hepatitis C infection on outcomes after heart transplantation. Transplantation 2009; 88: 1137.
3. Dominguez-Gil B, Morales JM. Transplantation in the patient with hepatitis C. Transpl Int 2009; 22: 1117.
4. Fabrizi F, Martin P, Dixit V, et al. Hepatitis C virus antibody status and survival after renal transplantation: Meta-analysis of observational studies. Am J Transplant 2005; 5: 1452.
5. Fabrizi F, Martin P, Ponticelli C. Hepatitis C virus infection and renal transplantation. Am J Kidney Dis 2001; 38: 919.
6. Legendre C, Garrigue V, Le Bihan C, et al. Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients. Transplantation 1998; 65: 667.
7. Mahmoud IM, Elhabashi AF, Elsawy E, et al. The impact of hepatitis C virus viremia on renal graft and patient survival: A 9-year prospective study. Am J Kidney Dis 2004; 43: 131.
8. Ridruejo E, Cusumano A, Diaz C, et al. Hepatitis C virus infection and outcome of renal transplantation. Transplant Proc 2007; 39: 3127.
9. Watt K, Veldt B, Charlton M. A practical guide to the management of HCV infection following liver transplantation. Am J Transplant 2009; 9: 1707.
10. Pereira BJ, Natov SN, Bouthot BA, et al. Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group. Kidney Int 1998; 53: 1374.
11. Roth D, Zucker K, Cirocco R, et al. A prospective study of hepatitis C virus infection in renal allograft recipients. Transplantation 1996; 61:886.
12. Fabrizi F, Martin P, Dixit V, et al. Post-transplant diabetes mellitus and HCV seropositive status after renal transplantation: Meta-analysis of clinical studies. Am J Transplant 2005; 5: 2433.
13. Stehman-Breen CO, Psaty BM, Emerson S, et al. Association of hepatitis C virus infection with mortality and graft survival in kidney-pancreastransj plant recipients. Transplantation 1997; 64: 281.
14. Honaker MR, Stratta RJ, LoA, et al. Impactof hepatitisC virus status in pancreas transplantation: A case controlled study. Clin Transplant 2002; 16: 243.
15. Batty DS Jr, Swanson SJ, Kirk AD, et al. Hepatitis C virus seropositivity at the time of renal transplantation in the United States: Associated factors and patient survival. Am J Transplant 2001; 1: 179.
16. Gruessner AC, Sutherland DE. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant 2005; 19: 433.
17. Hoofnagle JH. A step forward in therapy for hepatitis C. N Engl J Med 2009; 360: 1899.
18. Kamar N, Ribes D, Izopet J, et al. Treatment of hepatitis C virus infection (HCV) after renal transplantation: Implications for HCV-positive dialysis patients awaitingakidney transplant. Transplantation2006; 82: 853.
19. Cruzado JM, Casanovas-Taltavull T, Torras J, et al. Pretransplant in-terferon prevents hepatitis C virus-associated glomerulonephritis in renal allografts by HCV-RNA clearance. Am J Transplant 2003; 3: 357.
20. Fabrizi F, Lampertico P, Lunghi G, et al. Review article: Hepatitis C virus infection and type-2 diabetes mellitus in renal diseases and transplantation. Aliment Pharmacol Ther 2005; 21: 623.
21. Gordon CE, Balk EM, Becker BN, et al. KDOQI US commentary on the KDIGO clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in CKD. Am J Kidney Dis 2008; 52: 811.
22. Choy BY, Chan TM, Lai KN. Recurrent glomerulonephritis after kidney transplantation. Am J Transplant 2006; 6: 2535.
23. Gallay BJ, Alpers CE, Davis CL, et al. Glomerulonephritis in renal allo-grafts associated with hepatitisC infection: A possible relationship with transplant glomerulopathy in two cases. Am J Kidney Dis 1995; 26: 662.
24. 2009 USRDS annual report: Atlas of end-stage renal disease in the United States. National Institutes of Health and National Institute of Diabetes &Digestive &Kidney Diseases. p 24. Availableat: www.usrds.org/2009/ slides/indiv/INDEX-ESRD.HTML.
25. Alric L, Di-Martino V, Selves J, et al. Long-term impact of renal transplantation on liver fibrosis during hepatitis C virus infection. Gastroenterology 2002; 123: 1494.
26. Hanafusa T, Ichikawa Y, Kishikawa H, et al. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years. Transplantation 1998; 66: 471.
27. Kamar N, Rostaing L, Selves J, et al. Natural history of hepatitis C virus-related liver fibrosis after renal transplantation. Am J Transplant 2005; 5: 1704.
28. Mathurin P, Mouquet C, Poynard T, et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999; 29: 257.